WHEELING, Ill., July 22, 2025 — EdgeOne Medical, a professional service organization focused on device development service for combination products in the bio-pharmaceutical industry is pleased to announce the appointment of Mr. Michael Denzer as Vice President of Client Relations.
Michael brings over 30 years of extensive experience leading the development, commercialization, and lifecycle management of innovative packaging and combination products. His impressive track record spans a diverse range of drug delivery modalities, including respiratory products, small and large molecule injectables, and other advanced modes of administration that improve patient outcomes and enhance therapeutic efficacy.
Throughout his distinguished career, Mr. Denzer has held pivotal roles at leading pharmaceutical and biotech programs at companies including Schering-Plough (now Merck), Bristol Myers Squibb (BMS), Amgen, Otsuka, Shire, Teva, and most recently Civica. His deep industry knowledge and proven leadership have consistently driven projects from concept to commercialization, ensuring that life-changing therapies reach patients safely, effectively, and most efficiently.
“Michael’s passion for problem solving and bringing new treatments to patients, combined with his deep understanding of both client and service provider perspectives within the combination product ecosystem, makes him an exceptional addition to our leadership team,” said Lilli Zakarija, President of EdgeOne Medical.
“I am honored to join the EdgeOne Medical team who have distinguished themselves as a premier medical device combination product services provider. I’m focused on bringing my years of experience to this team in order to continue solving client problems through seasoned experience and innovative solutions,” stated Michael Denzer. “This role reflects what matters most to me: helping bring transformative treatments to our families and people who need them and making sure drug developers have the expertise to make that possible.”
Mr. Denzer’s appointment reflects EdgeOne Medical’s ongoing dedication to fostering strong client partnerships and delivering best-in-class device development services. His leadership will play a vital role in advancing the company’s mission to support innovative combination products that improve patient outcomes worldwide.